Literature DB >> 15156343

[Optical coherence tomography in the diagnosis and follow-up of patients with uveitic macular edema].

E K Reinthal1, M Völker, N Freudenthaler, M Grüb, M Zierhut, T Schlote.   

Abstract

BACKGROUND: Optical coherence tomography (OCT) is a relatively new, noninvasive method and has been well established as an effective diagnostic procedure for the investigation of several macular diseases. Knowledge about the efficacy of OCT in the diagnosis and follow-up of macular edema in uveitis patients is still limited. PATIENTS AND METHODS: In the first part of the study, OCT was performed in 22 eyes of 18 patients with anterior or intermediate uveitis who showed angiographic and fundoscopic evidence of macular edema. The OCT results were compared with the visual acuity and fundoscopic and angiographic appearance of macular edema. In the second part of the study, the same patients were followed over a period of approximately 5 months (+/-2 months) and OCT was repeated at different time points during treatment of uveitic macula edema.
RESULTS: OCT investigation also showed clear evidence of macular edema in all eyes and was not compromised by a low or medium degree of optical haze. Furthermore, OCT investigation revealed marked differences in the individual degree of macular edema (foveal heights 168-810 microm). Diffuse macular edema ( n = 4 ) and different types of cystoid macular edema (several distinguished cysts n = 6, partially or completely confluent cysts n = 11, one marked cyst n = 1) were observed. During the follow-up of the patients, OCT results, visual acuity, and fundoscopic appearance of the macula showed a comparable behavior. In some eyes, a stable visual acuity was accompanied by changes of foveal edema demonstrated by OCT.
CONCLUSION: Optical coherence tomography is a safe and highly effective method in the diagnosis of macular edema in uveitis associated with low or medium haze of the optical media. Furthermore, OCT investigation seems to be useful in the follow-up of uveitic macular edema under treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15156343     DOI: 10.1007/s00347-004-0996-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  16 in total

1.  Optical coherence tomography of age-related macular degeneration and choroidal neovascularization.

Authors:  M R Hee; C R Baumal; C A Puliafito; J S Duker; E Reichel; J R Wilkins; J G Coker; J S Schuman; E A Swanson; J G Fujimoto
Journal:  Ophthalmology       Date:  1996-08       Impact factor: 12.079

2.  Characterization of epiretinal membranes using optical coherence tomography.

Authors:  J R Wilkins; C A Puliafito; M R Hee; J S Duker; E Reichel; J G Coker; J S Schuman; E A Swanson; J G Fujimoto
Journal:  Ophthalmology       Date:  1996-12       Impact factor: 12.079

3.  Complications of chronic cyclitis.

Authors:  R E Smith; W A Godfrey; S J Kimura
Journal:  Am J Ophthalmol       Date:  1976-08       Impact factor: 5.258

4.  Anaphylactoid reaction to intravenously administered fluorescein.

Authors:  F G LaPiana; R Penner
Journal:  Arch Ophthalmol       Date:  1968-02

5.  Optical coherence tomography of macular holes.

Authors:  M R Hee; C A Puliafito; C Wong; J S Duker; E Reichel; J S Schuman; E A Swanson; J G Fujimoto
Journal:  Ophthalmology       Date:  1995-05       Impact factor: 12.079

6.  Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.

Authors:  R J Antcliff; D J Spalton; M R Stanford; E M Graham; T J ffytche; J Marshall
Journal:  Ophthalmology       Date:  2001-04       Impact factor: 12.079

7.  Topography of diabetic macular edema with optical coherence tomography.

Authors:  M R Hee; C A Puliafito; J S Duker; E Reichel; J G Coker; J R Wilkins; J S Schuman; E A Swanson; J G Fujimoto
Journal:  Ophthalmology       Date:  1998-02       Impact factor: 12.079

8.  Macular thickening and visual acuity. Measurement in patients with cystoid macular edema.

Authors:  R B Nussenblatt; S C Kaufman; A G Palestine; M D Davis; F L Ferris
Journal:  Ophthalmology       Date:  1987-09       Impact factor: 12.079

9.  Optical coherence tomography of central serous chorioretinopathy.

Authors:  M R Hee; C A Puliafito; C Wong; E Reichel; J S Duker; J S Schuman; E A Swanson; J G Fujimoto
Journal:  Am J Ophthalmol       Date:  1995-07       Impact factor: 5.258

10.  Quantitative assessment of macular edema with optical coherence tomography.

Authors:  M R Hee; C A Puliafito; C Wong; J S Duker; E Reichel; B Rutledge; J S Schuman; E A Swanson; J G Fujimoto
Journal:  Arch Ophthalmol       Date:  1995-08
View more
  8 in total

1.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

2.  Prospective optical coherence tomographic evaluation of the efficacy of oral and posterior subtenon corticosteroids in patients with intermediate uveitis.

Authors:  Pradeep Venkatesh; Zaheer Abhas; Satpal Garg; Rajpal Vohra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-02       Impact factor: 3.117

3.  Fundus autofluorescence and spectral domain optical coherence tomography in uveitic macular edema.

Authors:  Martin Roesel; Andreas Henschel; Carsten Heinz; Martha Dietzel; Georg Spital; Arnd Heiligenhaus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-11       Impact factor: 3.117

Review 4.  [Early antiexudative response--OCT monitoring after intravitreal bevacizumab injection].

Authors:  M Völcker; S Peters; W Inhoffen; F Ziemssen
Journal:  Ophthalmologe       Date:  2006-06       Impact factor: 1.059

5.  Evaluation of central serous retinopathy with en face optical coherence tomography.

Authors:  M E J van Velthoven; F D Verbraak; P M Garcia; R O Schlingemann; R B Rosen; M D de Smet
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

6.  Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis.

Authors:  Robert J Barry; Mohammad O Tallouzi; Nick Bucknall; Jonathan M Mathers; Philip I Murray; Melanie J Calvert; David J Moore; Alastair K Denniston
Journal:  Cochrane Database Syst Rev       Date:  2018-12-18

7.  A cross-sectional study of submacular thickening in intermediate uveitis and determination of treatment threshold.

Authors:  Bruno Simonazzi; Konstantinos Balaskas; Yan Guex-Crosier
Journal:  BMC Ophthalmol       Date:  2016-05-18       Impact factor: 2.209

8.  The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol.

Authors:  Mohammad O Tallouzi; David J Moore; Melanie Calvert; Philip I Murray; Nicholas Bucknall; Alastair K Denniston
Journal:  Syst Rev       Date:  2016-02-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.